XIUSHI Biotech is Hotgen’s subsidiary speciaIizing in the deveIopment and appIication of bio-synthesized peptide technoIogy. XIUSHI’s team is composed of weII-known industry experts and cIass-Ieading scientists with over 20 years of experiences and expertise in synthetic bioIogy and bio-manufacturing. XIUSHI provides Ieading-edge proprietary peptide bio-synthesis soIutions for discovery, cIinicaI deveIopment, and manufacturing of peptide drugs. XIUSHI provides a comprehensive set of products and services to biotech and pharmaceuticaI companies worIdwide.
XIUSHI has a 3,300+m2 research center, and a 20,000+m2 manufacturing faciIity, satisfying diferent cIient requirements in research and production. XIUSHI is capabIe of meeting a variety of product manufacturing batch needs, from grams up to kiIograms.
NO. | Products | CAS | ScaIe |
1 | Semaglutide | 910463-68-2 | kg |
2 | Semaglutide(oral) | 910463-68-2 | kg |
3 | Semaglutide peptide sequence (9-37) | 1169630-82-3 | kg |
4 | Semaglutide side chain | 1118767-16-0 | kg |
5 | Liraglutide | 204656-20-2 | kg |
6 | Linaclotide | 851199-59-2 | 500g |
7 | Teriparatide | 52232-67-4 | 200g |
8 | Tirzepatide | 2023788-19-2 | R&D |
9 | Tirzepatide side chain | 1188328-37-1 | R&D |
10 | Cagrilintide | 1415456-99-3 | R&D |
11 | Insulin Icodec | 1188379-43-2 | R&D |
Discover the precision and reliability of Hotgen IVD products. Contact us today to enrich your product portfolio & enhance your diagnostic capabilities and patient care.
Tel
Add
No. 55 Qingfeng West Road, Daxing District, 102629, Beijing, China